Results 1-5 of 5
5 February 2019
International law firm Clifford Chance has advised Merck KGaA (Merck) on the conclusion of a global strategic cooperation agreement with GlaxoSmithKline (GSK). The two companies will work together closely in the field of immuno-oncology. The cooperation concerns...
Pharmaceuticals pricing: Clifford Chance wins landmark ruling for GlaxoSmithKline at German Federal Social Court
6 July 2018
The German Federal Social Court (BSG) has confirmed the common price-building practice between the pharmaceuticals industry and health insurance associations when introducing new medicinal drugs to the market. Prior to this judgment, the Regional Social Court of...
25 April 2017
Clifford Chance advised Fresenius Kabi on the acquisition of Merck KGaA’s biosimilars business. Fresenius Kabi is an affiliate of Fresenius KGaA & Co. SE. The acquisition comprises the entire development pipeline and the product pipeline which has a focus on oncology...
19 December 2016
Clifford Chance advised SCA Group, Stockholm, Sweden, with a cross-border team on the takeover of medical solutions company BSN medical. The purchase price amounts to EUR 2.74 billion. The completion of the transaction is subject to customary regulatory approvals....
1 September 2014
As of 1 September 2014, Dr. Peter Dieners (52) is the new Managing Partner of Clifford Chance in Germany. He follows Dr. Andreas Dietzel (55), who had been elected Managing Partner of the German firm in 2010. The term in office for Dr. Peter Dieners will...